Science Historical Cash Flow

SIS Stock   26.50  0.50  1.92%   
Analysis of Science In cash flow over time is an excellent tool to project Science in Sport future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 6.6 M or Other Non Cash Items of 2.8 M as it is a great indicator of Science In ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Science in Sport latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Science in Sport is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science in Sport. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Science Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Science balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Science's non-liquid assets can be easily converted into cash.

Science In Cash Flow Chart

At present, Science In's Free Cash Flow is projected to decrease significantly based on the last few years of reporting. The current year's Change In Working Capital is expected to grow to about 5.9 M, whereas Begin Period Cash Flow is forecasted to decline to about 883.5 K.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Science in Sport to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Science In operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Science In's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Science in Sport current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science in Sport. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At present, Science In's Free Cash Flow is projected to decrease significantly based on the last few years of reporting. The current year's Change In Working Capital is expected to grow to about 5.9 M, whereas Begin Period Cash Flow is forecasted to decline to about 883.5 K.
 2023 2024 (projected)
Capital Expenditures2.1M2.2M
Dividends Paid45K40K

Science In cash flow statement Correlations

0.15-0.250.05-0.470.270.440.29-0.24-0.33-0.14-0.070.4-0.23-0.44-0.560.45-0.27
0.150.480.35-0.5-0.12-0.14-0.410.280.470.49-0.11-0.07-0.42-0.16-0.350.620.17
-0.250.480.74-0.5-0.130.1-0.760.41-0.040.81-0.35-0.17-0.420.02-0.220.520.13
0.050.350.74-0.470.550.51-0.26-0.28-0.140.890.060.5-0.12-0.34-0.60.44-0.46
-0.47-0.5-0.5-0.470.020.060.35-0.250.52-0.530.64-0.220.610.540.54-0.76-0.13
0.27-0.12-0.130.550.020.590.62-0.9-0.10.280.580.880.43-0.37-0.53-0.04-0.91
0.44-0.140.10.510.060.590.19-0.55-0.080.150.380.430.26-0.07-0.350.08-0.69
0.29-0.41-0.76-0.260.350.620.19-0.68-0.05-0.530.520.480.630.020.03-0.23-0.68
-0.240.280.41-0.28-0.25-0.9-0.55-0.680.03-0.04-0.68-0.87-0.60.420.340.290.76
-0.330.47-0.04-0.140.52-0.1-0.08-0.050.03-0.060.55-0.30.210.390.2-0.170.04
-0.140.490.810.89-0.530.280.15-0.53-0.04-0.06-0.110.35-0.36-0.45-0.590.35-0.09
-0.07-0.11-0.350.060.640.580.380.52-0.680.55-0.110.350.640.12-0.05-0.33-0.59
0.4-0.07-0.170.5-0.220.880.430.48-0.87-0.30.350.350.24-0.75-0.650.01-0.64
-0.23-0.42-0.42-0.120.610.430.260.63-0.60.21-0.360.640.240.280.49-0.34-0.5
-0.44-0.160.02-0.340.54-0.37-0.070.020.420.39-0.450.12-0.750.280.7-0.080.01
-0.56-0.35-0.22-0.60.54-0.53-0.350.030.340.2-0.59-0.05-0.650.490.7-0.30.35
0.450.620.520.44-0.76-0.040.08-0.230.29-0.170.35-0.330.01-0.34-0.08-0.3-0.03
-0.270.170.13-0.46-0.13-0.91-0.69-0.680.760.04-0.09-0.59-0.64-0.50.010.35-0.03
Click cells to compare fundamentals

Science In Account Relationship Matchups

Science In cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory961K(833K)(1.5M)1.8M(126K)(132.3K)
Change In Cash(2.6M)5.1M(5.6M)(3.9M)1.2M1.3M
Free Cash Flow(2.5M)1.0M(6.7M)(16.6M)1.1M1.2M
Change In Working Capital1.0M2.0M(1.5M)(3.9M)5.6M5.9M
Begin Period Cash Flow8.0M5.4M10.5M4.9M930K883.5K
Other Cashflows From Financing Activities(178K)(479K)(413K)(1.8M)(1.8M)(1.7M)
Depreciation2.8M3.2M3.6M4.8M6.3M6.6M
Other Non Cash Items5.7M47K112K757K2.7M2.8M
Capital Expenditures2.4M2.1M6.5M8.0M2.1M2.2M
Total Cash From Operating Activities(80K)3.1M(162K)(8.6M)3.2M3.4M
Net Income(5.6M)(1.7M)(6.8M)(10.9M)(11.3M)(10.7M)
Total Cash From Financing Activities(178K)4.1M1.1M12.7M324K307.8K
End Period Cash Flow5.4M10.5M4.9M930K2.1M2.0M
Change To Account Receivables(2.0M)1.1M(2.8M)(3.7M)2.7M2.8M
Total Cashflows From Investing Activities(2.4M)(2.1M)(6.5M)(8.0M)(7.2M)(7.5M)
Change To Netincome1.7M(319K)4.5M1.4M1.6M1.5M
Change To Liabilities2.1M1.8M2.8M(2.0M)(2.3M)(2.2M)
Stock Based Compensation1.9M1.2M226K2.9M262K0.0
Investments(2.4M)(2.1M)(6.5M)(8.0M)(2.1M)(2.2M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Science Stock

The Cash Flow Statement is a financial statement that shows how changes in Science balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Science's non-liquid assets can be easily converted into cash.